Overview
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Description
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Eligibility
Inclusion Criteria:
- 18 years or older in age
- Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- Able to read and understand the study information in Spanish
- Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- Subject is willing and able to comply with the scheduled questionnaires
Exclusion Criteria:
- Subjects who do not meet the criteria in section 4.1